Egalet

Egalet a/s

Lejrvej 37-41

Kirke Vaerloese

DK-3500 Vaerloese

Peter Nordkild

President & CEO

Mail: pn@egalet.com

Tel: +45 44 47 80 80

Web: http://www.egalet.com

Egalet a/s is focused on the development of innovative pharmaceutical products utilizing the Company’s proprietary, erosion-based, controlled- release technology, Egalet®, and a novel formulation system, Parvulet®, aimed at the pediatric market.

 

News
25 July
Sunstone Capital Raises EUR 180 Million
In a Second Closing in the fundraising Sunstone Capital has raised a total of approximately EUR 21 million...
19 June
ACE BioSciences and PATH Announce New Collaboration
ACE BioSciences A/S and PATH have announced a new partnership to advance the development of a vaccine against diarrheal disease...
Events Calendar
26 September, 08:00 - 17:00
4th Swiss-Scandinavian Bio-Business Seminar
forsker_1_212x150